| The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016 | 4267 | 2016 |
| Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer International Adjuvant Lung Cancer Trial Collaborative Group New England Journal of Medicine 350 (4), 351-360, 2004 | 3028 | 2004 |
| First-line nivolumab in stage IV or recurrent non–small-cell lung cancer DP Carbone, M Reck, L Paz-Ares, B Creelan, L Horn, M Steins, E Felip, ... New England Journal of Medicine 376 (25), 2415-2426, 2017 | 2583 | 2017 |
| Small-cell lung cancer JP Van Meerbeeck, DA Fennell, DKM De Ruysscher The Lancet 378 (9804), 1741-1755, 2011 | 1258 | 2011 |
| Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer JP Van Meerbeeck, GWPM Kramer, PEY Van Schil, C Legrand, EF Smit, ... Journal of the National Cancer Institute 99 (6), 442-450, 2007 | 808 | 2007 |
| Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ... European Respiratory Journal 35 (3), 479-495, 2010 | 774 | 2010 |
| Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial JT Annema, JP Van Meerbeeck, RC Rintoul, C Dooms, E Deschepper, ... Jama 304 (20), 2245-2252, 2010 | 729 | 2010 |
| Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for … JP van Meerbeeck, R Gaafar, C Manegold, RJ Van Klaveren, ... Journal of Clinical Oncology 23 (28), 6881-6889, 2005 | 724 | 2005 |
| Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data NSCLC Meta-analyses Collaborative Group The Lancet 375 (9722), 1267-1277, 2010 | 717 | 2010 |
| Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations PK Paik, E Felip, R Veillon, H Sakai, AB Cortot, MC Garassino, J Mazieres, ... New England Journal of Medicine 383 (10), 931-943, 2020 | 713 | 2020 |
| COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ... The Lancet Oncology 21 (7), 914-922, 2020 | 669 | 2020 |
| The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth … WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ... Journal of Thoracic Oncology 11 (8), 1204-1223, 2016 | 643 | 2016 |
| Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. D Curran, T Sahmoud, P Therasse, J van Meerbeeck, PE Postmus, ... Journal of Clinical Oncology 16 (1), 145-152, 1998 | 627 | 1998 |
| Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up L Crino, W Weder, J Van Meerbeeck, E Felip Annals of oncology 21, v103-v115, 2010 | 600 | 2010 |
| Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial C Faivre-Finn, M Snee, L Ashcroft, W Appel, F Barlesi, A Bhatnagar, ... The Lancet Oncology 18 (8), 1116-1125, 2017 | 531 | 2017 |
| Proteomic analysis of exosomes isolated from human malignant pleural effusions MP Bard, JP Hegmans, A Hemmes, TM Luider, R Willemsen, ... American journal of respiratory cell and molecular biology 31 (1), 114-121, 2004 | 514 | 2004 |
| The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer K Chansky, JP Sculier, JJ Crowley, D Giroux, J Van Meerbeeck, ... Journal of thoracic oncology 4 (7), 792-801, 2009 | 490 | 2009 |
| Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of … D Gilligan, M Nicolson, I Smith, H Groen, O Dalesio, P Goldstraw, ... The Lancet 369 (9577), 1929-1937, 2007 | 440 | 2007 |
| Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non–small-cell lung cancer: a phase III trial of the European … EF Smit, JPAM van Meerbeeck, P Lianes, C Debruyne, C Legrand, ... Journal of Clinical Oncology 21 (21), 3909-3917, 2003 | 433 | 2003 |
| The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer K Chansky, FC Detterbeck, AG Nicholson, VW Rusch, E Vallières, ... Journal of Thoracic Oncology 12 (7), 1109-1121, 2017 | 426 | 2017 |
